SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001387131-19-000063
Filing Date
2019-01-03
Accepted
2019-01-03 17:28:07
Documents
42

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_010219.htm 425 52175
2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION ex2-1.htm EX-2.1 631457
3 FORM OF SUPPORT AGREEMENT - OHR PHARMACEUTICAL, INC. ex2-2.htm EX-2.2 54826
4 FORM OF SUPPORT AGREEMENT - NEUBASE THERAPEUTICS, INC. ex2-3.htm EX-2.3 62796
5 FORM OF COMPANY AND NEUBASE LOCK-UP AGREEMENTS ex2-4.htm EX-2.4 26525
6 RETENTION BONUS AGREEMENT ex10-1.htm EX-10.1 18683
7 PRESS RELEASE ex99-1.htm EX-99.1 29595
8 NEUBASE THERAPEUTICS, INC. CORPORATE PRESENTATION, JANUARY 2019 ex99-2.htm EX-99.2 46031
9 GRAPHIC ex99-2_img01.jpg GRAPHIC 99422
10 GRAPHIC ex99-2_img02.jpg GRAPHIC 246761
11 GRAPHIC ex99-2_img03.jpg GRAPHIC 158903
12 GRAPHIC ex99-2_img04.jpg GRAPHIC 170101
13 GRAPHIC ex99-2_img05.jpg GRAPHIC 115728
14 GRAPHIC ex99-2_img06.jpg GRAPHIC 141629
15 GRAPHIC ex99-2_img07.jpg GRAPHIC 193754
16 GRAPHIC ex99-2_img08.jpg GRAPHIC 108767
17 GRAPHIC ex99-2_img09.jpg GRAPHIC 134579
18 GRAPHIC ex99-2_img10.jpg GRAPHIC 160976
19 GRAPHIC ex99-2_img11.jpg GRAPHIC 97613
20 GRAPHIC ex99-2_img12.jpg GRAPHIC 148779
21 GRAPHIC ex99-2_img13.jpg GRAPHIC 117406
22 GRAPHIC ex99-2_img14.jpg GRAPHIC 180088
23 GRAPHIC ex99-2_img15.jpg GRAPHIC 148294
24 GRAPHIC ex99-2_img16.jpg GRAPHIC 154218
25 GRAPHIC ex99-2_img17.jpg GRAPHIC 109311
26 GRAPHIC ex99-2_img18.jpg GRAPHIC 137978
27 GRAPHIC ex99-2_img19.jpg GRAPHIC 185082
28 GRAPHIC ex99-2_img20.jpg GRAPHIC 150273
29 GRAPHIC ex99-2_img21.jpg GRAPHIC 136454
30 GRAPHIC ex99-2_img22.jpg GRAPHIC 190221
31 GRAPHIC ex99-2_img23.jpg GRAPHIC 111950
32 GRAPHIC ex99-2_img24.jpg GRAPHIC 93725
33 GRAPHIC ex99-2_img25.jpg GRAPHIC 204627
34 GRAPHIC ex99-2_img26.jpg GRAPHIC 114803
35 GRAPHIC ex99-2_img27.jpg GRAPHIC 138400
36 GRAPHIC ex99-2_img28.jpg GRAPHIC 139408
37 GRAPHIC ex99-2_img29.jpg GRAPHIC 117933
38 GRAPHIC ex99-2_img30.jpg GRAPHIC 135242
39 GRAPHIC ex99-2_img31.jpg GRAPHIC 158785
40 GRAPHIC ex99-2_img32.jpg GRAPHIC 99489
41 GRAPHIC ex99-2_img33.jpg GRAPHIC 59127
42 GRAPHIC ex99-2_img34.jpg GRAPHIC 165826
  Complete submission text file 0001387131-19-000063.txt   7574943
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filed by) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 425 | Act: 34 | File No.: 001-35963 | Film No.: 19507135
SIC: 2834 Pharmaceutical Preparations